Epoetin Alfa: all 215 studies that test it
Page 3 of 3. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and AnemiaCompletedNCT00017004Phase 3
- Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia IntermediaCompletedNCT00006136Phase 2
- Radiation Therapy With or Without Epoetin Alfa in Treating Anemic Patients With Head and Neck CancerCompletedNCT00004917Phase 3
- Exercise Plus Epoetin Alfa in Treating Cancer Patients Who Have Anemia-Related FatigueCompletedNCT00004914Phase 2
- Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic SyndromeStatus unknownNCT00003681Phase 2
- Epoetin Alfa in Treating Anemia in Patients Who Are Receiving ChemotherapyCompletedNCT00003600Phase 3
- Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By ChemotherapyCompletedNCT00003341Phase 3
- The Safety and Effectiveness of r-HuEPO in Patients With AIDS or Advanced AIDS-Related Complex (ARC) Who Are AnemicCompletedNCT00002303Not applicable
- The Safety and Effectiveness of r-HuEPO in Patients With AIDS and Anemia Caused by AIDS and Treatment With AZTCompletedNCT00002302Not applicable
- A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of Subcutaneous Doses of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT TherapyCompletedNCT00002073Not applicable
- A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT TherapyCompletedNCT00002072Not applicable
- A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT TherapyCompletedNCT00002071Not applicable
- A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS and Advanced ARC Patients With AnemiaCompletedNCT00002042Not applicable
- Treatment Program for Anemia in AIDS PatientsCompletedNCT00002022Not applicable
- EPOCH Chemotherapy +/- IL-12 for Previously Untreated and EPOCH Plus Rituximab for Previously Treated Patients With AIDS-Associated LymphomaCompletedNCT00001563Phase 2